| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/24/2006 | WO2006003519A3 Use of emulsions for intra: and periocular injection |
| 08/24/2006 | WO2006000229A3 Porous tablets as carriers for liquid formulations |
| 08/24/2006 | WO2005123044A3 Implantable device for treating disease states and methods of using same |
| 08/24/2006 | WO2005117844A3 Mucoadhesive nanocomposite delivery system |
| 08/24/2006 | WO2005094265A3 Self assembling activation agents targeted using active drug release |
| 08/24/2006 | WO2005084635A3 Pharmaceutical ocular preparations suitable for the treatment of the ocular surface and related disorders/diseases |
| 08/24/2006 | WO2005082413A3 Ciclesonide and glycopyrronium combination |
| 08/24/2006 | WO2005065709A3 Lyophilized antibody conjugate formulation |
| 08/24/2006 | WO2005017180A8 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
| 08/24/2006 | WO2005009375A3 Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof |
| 08/24/2006 | WO2004069134A8 Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology |
| 08/24/2006 | WO2003043627A8 New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma |
| 08/24/2006 | US20060190060 System and apparatus for controlled activation of acute use medical devices |
| 08/24/2006 | US20060190046 Method, system and device for treating disorders of the pelvic floor by electrical stimulation of the left and the right sacral nerves |
| 08/24/2006 | US20060189963 Multi-reservoir device for controlled drug delivery |
| 08/24/2006 | US20060189785 Using biocompatible, low molecular weighty, water solubler polymer; injectable |
| 08/24/2006 | US20060189749 Random copolymers and formulations useful for thermoforming and blow molding applications |
| 08/24/2006 | US20060189701 Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections |
| 08/24/2006 | US20060189700 Pharmaceutical compositions |
| 08/24/2006 | US20060189695 External preparation for improving coital function |
| 08/24/2006 | US20060189683 Parenteral formulation of mycophenolic acid, a salt or prodrug thereof |
| 08/24/2006 | US20060189677 Treatment of arrhythmia and the production of analgesia and local anesthesia by administering 1-[2-(3,4-dimethoxyphenyl)ethoxy]-2-(3-hydroxy-1-pyrrolidinyl)cyclohexane or a salt |
| 08/24/2006 | US20060189662 Novel liquid preparation |
| 08/24/2006 | US20060189660 5-(4-(2-N-methyl-N-(2-pyridyl)amido)ethoxy)benzyl thiazolidine - 2,4-dione and pharmaceutical compositions comprising the same |
| 08/24/2006 | US20060189587 Use for budesonide and formoterol |
| 08/24/2006 | US20060189586 Pharmaceutical compositions comprising active vitamin D compounds |
| 08/24/2006 | US20060189579 Method of stabilizing ascorbyl phosphate and salts thereof |
| 08/24/2006 | US20060189573 Solutions and films of glycated chitosan |
| 08/24/2006 | US20060189565 Pharmaceutical compositions of ganciclovir |
| 08/24/2006 | US20060189559 Method and system for treating hepatitis C |
| 08/24/2006 | US20060189554 Nanoparticle-Based vaccine delivery system containing adjuvant |
| 08/24/2006 | US20060189552 Dispenser for dispensing three or more actives |
| 08/24/2006 | US20060189542 Preventive or therapeutic composition for viral infectious disease |
| 08/24/2006 | US20060189500 Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 08/24/2006 | US20060189483 Metal-containing compositions, preparations and uses |
| 08/24/2006 | US20060188607 Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions |
| 08/24/2006 | US20060188583 In situ controlled release drug delivery system |
| 08/24/2006 | US20060188582 Double walled microcapsules with an outer thermoplastic wall and application process thereof |
| 08/24/2006 | US20060188581 selective irreversible inhibitor of the B-form of the enzyme monoamine oxidase used, for example, for the treatment of Parkinson's disease; R(+)-N-propargyl-1-aminoindan salts, in particular tartrate, esylate, mesylate, or sulfate salts |
| 08/24/2006 | US20060188579 Novel process |
| 08/24/2006 | US20060188578 Hyaluronic acid nanoparticles |
| 08/24/2006 | US20060188577 Element having bioactive substance fixed thereto |
| 08/24/2006 | US20060188576 Pirenzepine ophthalmic gel |
| 08/24/2006 | US20060188575 Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulators |
| 08/24/2006 | US20060188574 Controlled release lipoic acid |
| 08/24/2006 | US20060188573 Composite materials and particles |
| 08/24/2006 | US20060188572 Controlled release of S-methoprene and other active ingredients with activated carbon |
| 08/24/2006 | US20060188571 Mixing progesterone with water and adjuvants; drying; compaction |
| 08/24/2006 | US20060188570 Making a tablet for HIV and AIDS drug efavirenz; use of a superdisintegrant and disintegrant intragranularly to achieved a bioequivalent formulation; bioavailability |
| 08/24/2006 | US20060188569 Stable pharmaceutical formulations of zonisamide and methods for their manufacture |
| 08/24/2006 | US20060188568 Stable formulations of ace inhibitors and methods for preparation thereof |
| 08/24/2006 | US20060188567 Gelatin hard capsule enhancing the film strength |
| 08/24/2006 | US20060188566 Nanoparticulate formulations of docetaxel and analogues thereof |
| 08/24/2006 | US20060188565 Treating acute pain by administering a solid oral dosage of diclofenac or salt which also contains an excipient base,(alkali carbonate or bicarbonate) to generate a gaseous and alkaline environment upon ingestion;; disintegration time of <15 minutes, 5-30 minutes for maximum concentration in blood |
| 08/24/2006 | US20060188564 Cellulose hard capsule enhancing mechanical film strength |
| 08/24/2006 | US20060188563 Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis |
| 08/24/2006 | US20060188562 Materials and methods for drug delivery and uptake |
| 08/24/2006 | US20060188561 Pharmaceutical compositions for lipophilic drugs |
| 08/24/2006 | US20060188560 Delivery system for nucleic acids |
| 08/24/2006 | US20060188559 Dermatological serum comprised of alpha arbutin, bearberry extract, octyl stearate and polyolprepolymer-2, introduced onto the human skin in liposome form for ultra-deep penetration; skin lightening |
| 08/24/2006 | US20060188558 Transdermal systems having control delivery system |
| 08/24/2006 | US20060188557 Prepartaion for external percutaneous administration containing non-steroidal anti-inflammatory drug and interleukin-1 alpha production inhibitor |
| 08/24/2006 | US20060188554 Transdermal absorption preparation |
| 08/24/2006 | US20060188553 Facial cosmetic devices |
| 08/24/2006 | US20060188552 Forming a disposable glove of acrylonitrile, polyurethane, polychloroprene or polyvinyl chloride; chlorination washing of the inside surface; coating the surface with an emulsified mixture of Lanolin and Vitamin E; evaporating the liquid medium; drying the glove; minimizing skin damage |
| 08/24/2006 | US20060188551 Products comprising a sheet and a wax dispersion |
| 08/24/2006 | US20060188534 Dispersions for the formulation of slightly or poorly soluble agents |
| 08/24/2006 | US20060188532 Particularly drugs and cosmetic agents; an ethoxylated oil having between 10 and 19 ethoxy units, and the delivered agent, especially analgesics, antiinflammatory agents or antiwrinkle agents; improved penetration and bioavailability |
| 08/24/2006 | US20060188531 Particularly drugs and cosmetic agents; an ethoxylated oil, fatty acid, fatty alcohol, or fatty amine having between 10 and 19 ethoxy units, and the delivered agent, especially analgesics, antiinflammatory agents or antiwrinkle agents; improved penetration and bioavailability |
| 08/24/2006 | US20060188530 Bile preparations for gastrointestinal disorders |
| 08/24/2006 | US20060188529 Stable compositions of fenofibrate with fatty acid esters |
| 08/24/2006 | US20060188528 Spreadable warming lubricant |
| 08/24/2006 | US20060188525 Relieving spastic muscle pain; ultrasonic frequency disruption of stratum corneum and applying patch containing neurotoxin |
| 08/24/2006 | US20060188487 Blend hydrogels and methods of making |
| 08/24/2006 | US20060188464 Microencapsulation systems and applications of same |
| 08/24/2006 | US20060188463 Stable water-in-oil-in-water multiple emulsion system produced by hydrodynamic dual stabilization and a method for preparation thereof |
| 08/24/2006 | US20060188451 Aerogel based pharmaceutical formulations |
| 08/24/2006 | US20060188448 Theraputic Skin Treatment Method |
| 08/24/2006 | US20060185972 1,1,1,2-tetrafluoroethane containing organic impurities, is subjected to distillations, the second distillation being carried out at a pressure greater than that of first distillation, and purified hydrofluoroalkane is recovered |
| 08/24/2006 | DE202006008328U1 Device for creation of peripheral/non-lymphatic compartments, comprises molded article exhibiting turned side and inner side for implantation of skin, injection immune-modulating substances and permeable diaphragm |
| 08/24/2006 | DE102005007374A1 Nano-particle, useful e.g. as carriers for transport of active substances, comprises hydrophobic and biocompatible functionalized polymer, active material and/or marker |
| 08/24/2006 | DE102005007059A1 Teilneutralisiertes anionisches (Meth)acrylat-Copolymer Partially neutralized anionic (meth) acrylate copolymer |
| 08/24/2006 | CA2598410A1 Oral pharmaceutical for of losartan |
| 08/24/2006 | CA2598407A1 Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using them |
| 08/24/2006 | CA2598406A1 Method for a treatment with a medicament combination and medicament combinations suitable for the same |
| 08/24/2006 | CA2598364A1 Composition containing chitosan for sustained drug release |
| 08/24/2006 | CA2598316A1 Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative |
| 08/24/2006 | CA2598212A1 Composition for adjusting water quality for administration of water sanitizer sensitive medicaments or vaccines |
| 08/24/2006 | CA2597931A1 Apparatus and method for transdermal delivery of erythropoetin-based agents |
| 08/24/2006 | CA2597910A1 Dosage form and method for sustained release of a substituted pyrazine compound |
| 08/24/2006 | CA2597716A1 Aerosol and injectable formulations of nanoparticulate benzodiazepine |
| 08/24/2006 | CA2597651A1 Device for delivery of trpv1 agonists |
| 08/24/2006 | CA2597525A1 Solid ophthalmic drug for external use |
| 08/24/2006 | CA2596392A1 Orally bioavailable cci-779 tablet formulations |
| 08/24/2006 | CA2596011A1 Polymer particle delivery compositions and methods of use |
| 08/24/2006 | CA2595926A1 Soap scent patch and treatment for muscle spasm and pain |
| 08/24/2006 | CA2595411A1 Oral dosage form comprising rosiglitazone |
| 08/24/2006 | CA2595269A1 Composition comprising ocaperidone |
| 08/24/2006 | CA2594939A1 Solid peroral contraceptive drug |
| 08/23/2006 | EP1693445A1 Process for the preparation of yeast microcapsules |